| Dr Alvina Qureshi, OD | |
|
2201 E Fowler Ave Ste B, Tampa, FL 33612 | |
| (813) 972-1573 | |
| (813) 632-0563 |
| Full Name | Dr Alvina Qureshi |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 2201 E Fowler Ave Ste B, Tampa, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003212044 | NPI | - | NPPES |
| 5220 | Other | FL | FLORIDA STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 5064 (Massachusetts) | Secondary |
| 152W00000X | Optometrist | 5220 (Florida) | Primary |
| Provider Name | Myeyedr Optometry Of Georgia, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437294592 PECOS PAC ID: 8224261201 Enrollment ID: O20140428000739 |
News Archive
Bionovo, Inc. (Nasdaq: BNVI) announced today that it has entered into a common stock purchase agreement with Aspire Capital Fund LLC, an Illinois limited liability company, which provides that, subject to certain conditions and limitations, Aspire Capital is committed to purchase up to an aggregate of $15.0 million of Bionovo shares of common stock over a two year term, based on prevailing market prices over a period preceding each sale.
Despite growing evidence that the earlier people are diagnosed with HIV and get access to care, the better their clinical outcomes, many HIV-infected people in the United States and Canada are not receiving the care they need early enough.
BioDelivery Sciences International, Inc. announced that the company has been granted a meeting with the U.S. Food and Drug Administration (FDA) to discuss the planned Investigational New Drug (IND) application for BDSI's antiemetic (anti-nausea and vomiting) product candidate, BEMA Granisetron. The meeting will take place on March 17, 2010. The company will discuss with the FDA clinical development and regulatory plans for BEMA Granisetron, which is anticipated to enter Phase 1 studies in the second quarter of 2010.
After a person receives acute care in a "regular" hospital for catastrophic illness, traumatic injury or a debilitating chronic condition, the next step in the process of recovery often involves a stay at an inpatient rehabilitation, or rehab, facility.Patients often have little warning when they're quickly moved to a rehab facility from acute care. Those who envision a long, leisurely recovery in a hospital or at home may find that the abrupt transition-and new responsibilities in rehab-leaves their heads spinning.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alvina Qureshi, OD 27 Royal Crest Dr Apt 6, Marlborough, MA 01752-2426 Ph: () - | Dr Alvina Qureshi, OD 2201 E Fowler Ave Ste B, Tampa, FL 33612 Ph: (813) 972-1573 |
News Archive
Bionovo, Inc. (Nasdaq: BNVI) announced today that it has entered into a common stock purchase agreement with Aspire Capital Fund LLC, an Illinois limited liability company, which provides that, subject to certain conditions and limitations, Aspire Capital is committed to purchase up to an aggregate of $15.0 million of Bionovo shares of common stock over a two year term, based on prevailing market prices over a period preceding each sale.
Despite growing evidence that the earlier people are diagnosed with HIV and get access to care, the better their clinical outcomes, many HIV-infected people in the United States and Canada are not receiving the care they need early enough.
BioDelivery Sciences International, Inc. announced that the company has been granted a meeting with the U.S. Food and Drug Administration (FDA) to discuss the planned Investigational New Drug (IND) application for BDSI's antiemetic (anti-nausea and vomiting) product candidate, BEMA Granisetron. The meeting will take place on March 17, 2010. The company will discuss with the FDA clinical development and regulatory plans for BEMA Granisetron, which is anticipated to enter Phase 1 studies in the second quarter of 2010.
After a person receives acute care in a "regular" hospital for catastrophic illness, traumatic injury or a debilitating chronic condition, the next step in the process of recovery often involves a stay at an inpatient rehabilitation, or rehab, facility.Patients often have little warning when they're quickly moved to a rehab facility from acute care. Those who envision a long, leisurely recovery in a hospital or at home may find that the abrupt transition-and new responsibilities in rehab-leaves their heads spinning.
› Verified 9 days ago
Dr. Carlos Naguib, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 13904 N Dale Mabry Hwy Ste 200, Tampa, FL 33618 Phone: 954-706-2945 | |
Dr. William Henry Stephen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5885 Gunn Hwy, Tampa, FL 33625 Phone: 813-908-0100 Fax: 813-908-0099 | |
Dr. Barry A Aronson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11402 Georgetown Cir, Tampa, FL 33635 Phone: 813-383-6977 Fax: 413-793-8724 | |
Dr. Linhan T. Truong, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2201 E. Fowler Ave., Ste. B, Tampa, FL 33612 Phone: 813-972-1573 Fax: 813-972-3081 | |
Erin Swichkow Cooper, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 13602 N 46th St, Tampa, FL 33613 Phone: 813-972-4444 Fax: 813-979-1600 | |
South Tampa Eye Site Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4117 Henderson Blvd, Tampa, FL 33629 Phone: 813-207-8984 |